TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for ARG1
check button Gene summary
Basic gene informationGene symbolARG1
Gene namearginase 1
Synonyms-
CytomapUCSC genome browser: 6q23
Type of geneprotein-coding
RefGenesNM_000045.3,
NM_001244438.1,
Descriptionarginase, liverarginase-1liver-type arginasetype I arginase
Modification date20141219
dbXrefs MIM : 608313
HGNC : HGNC
Ensembl : ENSG00000118520
HPRD : 01947
Vega : OTTHUMG00000015566
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ARG1
BioGPS: 383
PathwayNCI Pathway Interaction Database: ARG1
KEGG: ARG1
REACTOME: ARG1
Pathway Commons: ARG1
ContextiHOP: ARG1
ligand binding site mutation search in PubMed: ARG1
UCL Cancer Institute: ARG1
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesTiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Liver
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)LIHC
Reference showing the relevant tissue of ARG1
Description by TissGene annotationsCancer gene
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for ARG1

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
LIHC10.5851041112.98651211-2.4014089.00E-074.84E-06
STAD-0.394855520.79043823-1.185293750.005310.020379164
HNSC1.0760194082.894579873-1.8185604650.00370.010471698
LUSC0.0361650071.093219909-1.0570549020.001550.002799198


Top
TissGene-miRNA for ARG1

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for ARG1
TissGeneSNV for ARG1

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.G235RSTAD1
p.R21QBRCA1
p.F162LBRCA1
p.I307VLIHC1
p.I299VLIHC1
p.G154ESKCM1
p.G305RUCEC1
p.T292ISKCM1
p.P144LLUSC1
p.A112VUCEC1
p.S16*LUAD1
p.S72YUCEC1
p.F15LBLCA1
p.I8TPAAD1
p.Y317HESCA1
p.P20SUCEC1
p.G178VSARC1
p.D52ELUAD1
p.P63LHNSC1
p.R255TSARC1
p.T166ISTAD1
p.G243RSTAD1
p.E38DBLCA1
p.F239VUCS1
p.V24LOV1
p.G235RPRAD1
p.E151KSKCM1
p.V84ELUSC1
p.F231VUCS1
p.T127NSKCM1
p.G283ESKCM1


Top
TissGeneCNV for ARG1

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for ARG1

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
TCGAfusionPortalPRADABRCATCGA-B6-A0IQ-01AMAP7-ARG1Out-of-frameChr6:136871480Chr6:131904200
TCGAfusionPortalPRADALUADTCGA-55-6978-01AATXN1-ARG15UTR-CDSChr6:16658007Chr6:131900251


Top
TissGeneNet for ARG1

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (tumor)ARG1, UBC, ESR1, RAD21, UCHL5, FLOT1, C12orf44, USP53, NOS1, ALDH4A1, ARG2 (normal)
bullet pointbullet point


Top
TissGeneProg for ARG1

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for ARG1
TissGeneDrug for ARG1

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status
DB03904UreaSmall moleculeApproved


Top
TissGeneDisease for ARG1

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0268548Hyperargininemia12BeFree,CLINVAR,CTD_human,MGD,ORPHANET,UNIPROT
umls:C0004096Asthma11BeFree,CTD_human,GAD,LHGDN
umls:C0003850Arteriosclerosis3BeFree
umls:C0004153Atherosclerosis3BeFree
umls:C0020538Hypertensive disease3LHGDN,RGD
umls:C0022116Ischemia3BeFree
umls:C0027051Myocardial Infarction3BeFree,GAD,LHGDN
umls:C0264408Childhood asthma3BeFree
umls:C2239176Liver carcinoma3BeFree
umls:C0007131Non-Small Cell Lung Carcinoma2BeFree
umls:C0007222Cardiovascular Diseases2BeFree
umls:C0014859Esophageal Neoplasms2BeFree
umls:C0020542Pulmonary Hypertension2BeFree,LHGDN
umls:C0027627Neoplasm Metastasis2BeFree,LHGDN
umls:C0027819Neuroblastoma2BeFree
umls:C0032927Precancerous Conditions2CTD_human,GAD
umls:C0037116Silicosis2CTD_human,RGD
umls:C0041296Tuberculosis2BeFree
umls:C0152018Esophageal carcinoma2BeFree
umls:C0546837Malignant neoplasm of esophagus2BeFree
umls:C0700095Central neuroblastoma2BeFree
umls:C0002514Amino Acid Metabolism, Inborn Errors1CTD_human
umls:C0003123Anorexia1BeFree
umls:C0003873Rheumatoid Arthritis1BeFree
umls:C0006274Bronchiolitis, Viral1GAD
umls:C0006287Bronchopulmonary Dysplasia1BeFree
umls:C0007134Renal Cell Carcinoma1BeFree
umls:C0008370Cholestasis1RGD
umls:C0009404Colorectal Neoplasms1LHGDN
umls:C0010068Coronary heart disease1BeFree,GAD
umls:C0011853Diabetes Mellitus, Experimental1RGD
umls:C0018500Hair Diseases1CTD_human
umls:C0018923Hemangiosarcoma1BeFree
umls:C0019196Hepatitis C1BeFree
umls:C0020440Hypercapnia1RGD
umls:C0021053Immune System Diseases1CTD_human
umls:C0021368Inflammation1GAD
umls:C0021655Insulin Resistance1RGD
umls:C0021833Intestinal Fistula1RGD
umls:C0023281Leishmaniasis1CTD_human
umls:C0023473Myeloid Leukemia, Chronic1BeFree
umls:C0023893Liver Cirrhosis, Experimental1RGD
umls:C0023895Liver diseases1RGD
umls:C0025202melanoma1BeFree
umls:C0025517Metabolic Diseases1BeFree
umls:C0026838Muscle Spasticity1BeFree
umls:C0026848Myopathy1CTD_human
umls:C0028754Obesity1BeFree
umls:C0033860Psoriasis1BeFree
umls:C0034069Pulmonary Fibrosis1BeFree
umls:C0035126Reperfusion Injury1RGD
umls:C0035235Respiratory Syncytial Virus Infections1GAD
umls:C0038356Stomach Neoplasms1GAD
umls:C0041956Ureteral obstruction1RGD
umls:C0042164Uveitis1RGD
umls:C0079487Helicobacter Infections1GAD
umls:C0079731B-Cell Lymphomas1BeFree
umls:C0085311Diffuse cutaneous leishmaniasis1BeFree
umls:C0085605Liver Failure1RGD
umls:C0149939Obstructive nephropathy1BeFree
umls:C0155877Allergic asthma1BeFree
umls:C0206624Hepatoblastoma1BeFree
umls:C0206698Cholangiocarcinoma1BeFree
umls:C0235557Pulmonary granuloma1BeFree
umls:C0241910Hepatitis, Autoimmune1LHGDN
umls:C0242706Hyperoxia1RGD
umls:C0267941Pancreatitis, Acute Necrotizing1RGD
umls:C0278694Disseminated neuroblastoma1BeFree
umls:C0340288Stable angina1BeFree
umls:C0376358Malignant neoplasm of prostate1BeFree
umls:C0392707Atopy1GAD
umls:C0426970Spastic Quadriplegia1BeFree
umls:C0497406Overweight1BeFree
umls:C0600139Prostate carcinoma1BeFree
umls:C0683322Mental impairment1BeFree
umls:C0751753Carbamoyl-Phosphate Synthase I Deficiency Disease1BeFree
umls:C0856169Endothelial dysfunction1BeFree
umls:C0856742Post MI1BeFree
umls:C0860207Drug-Induced Liver Injury1CTD_human
umls:C0949664Tauopathies1BeFree
umls:C1135161Stage 4S neuroblastoma1BeFree
umls:C1512409Hepatocarcinogenesis1BeFree
umls:C1800706Idiopathic Pulmonary Fibrosis1BeFree
umls:C2609414Acute kidney injury1RGD
umls:C3714753RETINOSCHISIS 1, X-LINKED, JUVENILE1BeFree